care & love
When a medical equipment distributor places a manufacturer's device on a new market, the documentation that travels with the product has to be right from day one. The Instructions for Use (IFU) is not just a printed booklet inside the box. It is a regulatory document that tells a clinician, a physiotherapist or a family caregiver exactly how to operate, maintain and clean a device safely. If that document arrives in the wrong language, or is translated carelessly, the device cannot legally be sold in that market — and, more importantly, patient safety can be put at risk.
For a distributor such as Mona Care, which supplies electric nursing beds, lower limb exoskeleton robots and B-CURE laser therapy devices to hospitals, rehabilitation departments and home users around the world, handling IFU translations is a core part of the job. This article explains how a medical equipment distributor should approach product IFU translations, from the regulatory background to the practical workflow that keeps every market compliant.
Under the EU Medical Device Regulation (Regulation (EU) 2017/745), a device placed on the market must carry an IFU in the official language or languages determined by each member state. In practice, a device sold across the European ｕｎｉｏｎ may need its documentation in up to 24 languages. Similar obligations apply in other regulated regions, and in the United Kingdom the UKCA marking scheme under the UK Medical Devices Regulations 2002 sets its own language requirements for the Great Britain market.
The manufacturer remains the owner of the master content and is responsible for regulatory validation. But the distributor, as the economic operator that actually places the product in front of local customers, carries the practical burden of making sure every market receives an accurate, complete and correctly translated IFU. In many distribution agreements, the distributor is contractually required to arrange qualified translation when the manufacturer does not supply a local-language version. That is why a distributor cannot simply forward the English manual and hope for the best.
IFU translation is rarely a one-document task. In a typical product portfolio, a distributor coordinates multilingual content across several document types at once:
For a distributor selling equipment such as a nursing bed or a rehabilitation exoskeleton, the stakes are high. A mistranslated warning on a bed that can lift, tilt and rotate a patient, or on a walking robot that supports a stroke survivor during gait training, is not a cosmetic problem. It is a safety problem. The same applies to a laser therapy device, where dosage and positioning instructions must be unambiguous in every language.
A reliable IFU translation process rests on four pillars: the right translators, controlled terminology, a documented quality workflow and certification.
General technical translators are not enough. A translator working on an exoskeleton IFU needs to understand rehabilitation terminology and how the device is used in a clinical setting. A translator working on a nursing bed manual needs to know the difference between backrest adjustment, leg lifting and tilt functions, and how those functions are described in the target market. The translator must understand not just the language, but the clinical context.
Consistency is a regulatory expectation. If the IFU uses one term and the label uses another, even in translation, that creates a compliance risk and a potential patient safety issue. Distributors should build an approved glossary for each product line and use translation memory software so that when a manual is revised for a new product generation, the previously approved translations are carried forward instead of being retranslated from scratch.
For regulated medical device documentation, the baseline is an ISO 17100:2015-certified workflow: translation by a qualified specialist, independent bilingual revision by a second qualified translator, final proofreading and quality check, and a documented process that can be shown to a notified body or a competent authority. This two-translator workflow is not optional for patient-facing content.
Each translated IFU should be accompanied by a Certificate of Accuracy confirming that the translation is complete, accurate and produced by qualified professionals. This certificate becomes part of the technical file and may be reviewed during conformity assessment or a manufacturer audit, so it should be stored with the same care as the translation itself.
Beyond the quality process, distributors need a clear operating routine. Start by defining who owns each step: the manufacturer approves the source content, the distributor manages the local-language review, and the translation provider guarantees linguistic quality. A distribution agreement or a simple responsibility matrix prevents confusion when a label changes or a new IFU revision arrives.
Version control matters just as much as translation quality. When a manufacturer updates an IFU following a design change or a post-market surveillance finding, every language version must be updated at the same time. Leaving an out-of-date translation on the shelf for any market is a compliance failure. Distributors should also plan translation early in the market-entry timeline. A large IFU translated into many languages at once can take four to six weeks, so treating translation as a final step before launch creates avoidable timeline risk.
Mona Care works directly with producers to bring genuine, high-quality life care products to customers, and that direct relationship extends to documentation. Because the company supplies complex equipment — from electric multifunction nursing beds with back lifting, leg lifting and turning functions, to lower limb exoskeleton robots such as Bear Adult, Rabbit Kid and Gait Assist, to B-CURE laser therapy devices — it treats every IFU as a safety-critical document. Each product line is reviewed with the same discipline: source content checked against the manufacturer, terminology kept consistent across the manual and the label, and translations verified before the device is offered in a new market.
For hospitals, rehabilitation departments and home caregivers, this means the equipment arrives with documentation they can actually rely on. Whether a physiotherapist is setting up a gait training session with an exoskeleton or a family is learning to adjust a nursing bed at home, the instructions match the device, the language and the way the equipment is really used.
IFU translation for medical equipment is a regulatory requirement, not a documentation chore. It demands specialist translators, controlled terminology, a documented quality process and disciplined version management across the full documentation set. For a distributor, getting this right is what allows a quality product to move smoothly from the factory floor to a hospital ward or a family home, in any language. When the manual is accurate, complete and available in the language of the user, the distributor has done its part to keep the device safe, compliant and genuinely ready for the market.